John Dobak, Chief Executive Officer at DermTech, Inc. (DMTK), sold 1,559 shares at $3.26 ($5K) on 2023-03-13, disclosed to the SEC on 2023-03-13.
Seasonal sale ($5k) by Chief Executive Officer — this insider has traded DMTK in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| DMTK | SELL | 2022-03-09 | $43K | — | Filing → |
| DMTK | SELL | 2021-12-16 | $33K | — | Filing → |
| DMTK | SELL | 2021-12-10 | $21K | — | Filing → |